Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial

BACKGROUND: The current absence of gold‐standard or all‐aspect favorable therapies for COVID‐19 renders a focus on multipotential drugs proposed to prevent or treat this infection or ameliorate its signs and symptoms vitally important. The present well‐designed randomized controlled trial (RCT) soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Atefi, Najmolsadat, Goodarzi, Azadeh, Riahi, Taghi, Khodabandehloo, Niloofar, Talebi Taher, Mahshid, Najar Nobari, Niloufar, Seirafianpour, Farnoosh, Mahdi, Zeinab, Baghestani, Amir, Valizadeh, Rohollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659758/
https://www.ncbi.nlm.nih.gov/pubmed/38018602
http://dx.doi.org/10.1002/iid3.1083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659758/
https://www.ncbi.nlm.nih.gov/pubmed/38018602
http://dx.doi.org/10.1002/iid3.1083

Ejemplares similares